Eminence Capital’s Monsanto Co MON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-230,190
Closed -$24.2M 47
2016
Q4
$24.2M Buy
+230,190
New +$23.6M 0.38% 44
2016
Q3
Sell
-1,897,730
Closed -$196M 49
2016
Q2
$196M Buy
1,897,730
+202,299
+12% +$20M 3.97% 5
2016
Q1
$149M Buy
1,695,431
+46,653
+3% +$4.21M 2.62% 13
2015
Q4
$162M Buy
1,648,778
+315
+0% +$29.6K 2.02% 16
2015
Q3
$141M Buy
1,648,463
+137,679
+9% +$13.6M 2.16% 18
2015
Q2
$161M Buy
1,510,784
+718,481
+91% +$83.4M 2.29% 18
2015
Q1
$89.2M Sell
792,303
-10,548
-1% -$1.25M 1.38% 33
2014
Q4
$95.9M Buy
802,851
+11,202
+1% +$1.3M 1.39% 34
2014
Q3
$89.1M Buy
791,649
+143,071
+22% +$16.7M 1.3% 32
2014
Q2
$80.9M Buy
+648,578
New +$75.9M 1.34% 33

Other funds holding MON

Eminence Capital's MON Position: Q1 2017 in Review

Eminence Capital sold out of Monsanto Co (MON) in Q1 2017, closing a stake of 230,190 shares — an estimated $24.2M sold.

Eminence Capital first reported a position in MON in Q2 2014 and held it in 10 quarters. The position peaked at $196M in Q2 2016. 1,021 funds tracked by Wall St. Rank hold MON as of Q1 2017.

  • Eminence Capital reported no remaining Monsanto Co position as of Q1 2017 after selling out during the quarter.
  • Eminence Capital sold 230,190 Monsanto Co shares in Q1 2017, an estimated $24.2M.
  • Eminence Capital first reported a position in Monsanto Co in Q2 2014 and held it in 10 quarters.
  • Eminence Capital's Monsanto Co position peaked at $196M in Q2 2016.
  • 1,021 funds tracked by Wall St. Rank held Monsanto Co as of Q1 2017.

Based on Eminence Capital's 13F filing for Q1 2017, filed 15 May 2017.